Eczema trials recruiting in California

All Eczema trials nationally

Cities in California

Recruiting trials in California

• A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
  NCT07558668 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Fremont
• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
  NCT07277660 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Oceanside, Santa Monica
• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
  NCT07223697 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
  NCT07003425 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Fountain Valley, Los Angeles
• A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
  NCT06807281 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · California: San Diego
• A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07643766 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Encinitas, Los Angeles, Northridge
• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07599813 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Huntington Beach, Los Angeles, Northridge, Sacramento
• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07711418 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · California: Oxnard, Palmdale, Sacramento
• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07690371 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · California: Fountain Valley, Los Angeles
• A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
  NCT05995964 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Huntington Beach, Los Angeles, Newport Beach, Northridge
• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
  NCT06808477 · Phase: Phase 1 · Ages: 18 Years to 72 Years · Sex: All (male and female) · California: Irvine
• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
  NCT06389136 · Phase: Phase 3 · Ages: 18 Years to 63 Years · Sex: All (male and female) · California: Chula Vista, Encino, Fountain Valley, Greenbrae
• A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
  NCT06807268 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · California: San Diego
• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
  NCT06461897 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · California: Palo Alto, Sacramento
• A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
  NCT06524635 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Sacramento
• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
  NCT07037901 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · California: Lancaster, Los Angeles
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
  NCT06241118 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · California: Encino, Fremont, Long Beach, Los Angeles
• A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
  NCT07216027 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · California: Huntington Beach, Los Angeles, Northridge, Santa Monica
• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
  NCT07765888 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · California: Northridge
• A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
  NCT06311682 · Phase: Phase 3 · Ages: 6 Months to 11 Years · Sex: All (male and female) · California: Palo Alto, Sacramento, San Diego
• Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT06397911 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Fountain Valley, Fremont, Los Angeles, Sacramento
• FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
  NCT06564389 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Anaheim, San Diego
• Lebrikizumab in Moderate-to-severe Atopic Dermatitis
  NCT06906497 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · California: Folsom
• Molecular Signatures of Cutaneous Dupilumab Response
  NCT05858619 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
  NCT05938478 · Phase: Not specified · Ages: No age limits stated · Sex: Female · California: La Jolla
• Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
  NCT07560618 · Phase: Phase 4 · Ages: 12 Years and older · Sex: All (male and female) · California: Sacramento
• Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
  NCT06947993 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · California: Fountain Valley, Los Angeles, Sacramento, Santa Ana
• Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
  NCT06899204 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · California: San Diego
• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
  NCT06988605 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · California: Corona, Fountain Valley, Fremont, Los Angeles
• Sodium in the Skin and Atopic Dermatitis
  NCT06998446 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · California: San Francisco
• Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07298395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Beverly Hills, Fremont, San Diego, Santa Monica
• Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
  NCT07441395 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: South San Francisco
• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
  NCT06504160 · Phase: Phase 1 · Ages: 6 Years and older · Sex: All (male and female) · California: San Diego
• The Impact of Dietary Salt on the Severity of Eczema
  NCT07447063 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
  NCT07487831 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
  NCT07290803 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · California: Bakersfield, Fremont, Los Angeles, Northridge